Eremophila neglecta
Eremophila neglecta · Accepted scientific name
Scientific literature: Very Sparse (3 studies) · ★☆☆☆☆
Eremophila neglecta is a plant species that has garnered scientific interest due to the potent biological activities found within its crude extract. Research has demonstrated that this botanical specimen possesses significant antibacterial and cytotoxic properties. Specifically, the extract has shown effectiveness against various pathogens, including Gram-positive bacteria, Moraxella catarrhalis, Mycobacterium chelonae, and Mycobacterium fortuitum. These biological effects are attributed to key chemical constituents such as 2,19-diacetoxy-8-hydroxyserrulat-14-ene and 8-hydroxyserrulat-14-en-19-oic acid. Understanding these compounds provides valuable insight into the therapeutic potential of this unique plant.
- Synonyms
- Stenochilus Neglectus
- Common names
- Not available
- Family
- Scrophulariaceae
- Distribution
- Africa
- Plant Parts
- Not available
Classification
Synonyms
Eremophila neglecta is a distinctive species within its genus that is often recognized by botanists under various taxonomic classifications. In scientific literature, this plant is frequently referred to by its synonym, Stenochilus neglectus. Understanding these naming connections is essential for researchers tracking the plant's evolutionary history and distribution. While the names may differ depending on the source, they both point to the same unique botanical entity. Consequently, mastering these synonymous relationships ensures accuracy when documenting the diverse flora of the region.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Eremophila neglecta belongs to the diverse kingdom Plantae, representing a unique branch of the natural world. Within this vast kingdom, the species is classified under the class Equisetopsida. It further falls into the order Lamiales, showcasing its evolutionary connections to related flowering plants. As a member of the Scrophulariaceae family, it shares specific biological characteristics with its botanical relatives. Ultimately, this plant is defined by its placement within the genus Eremophila.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Lamiales |
| Family | Scrophulariaceae |
| Genus | Eremophila |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Eremophila neglecta is a unique plant species found within the diverse landscapes of Australasia. Its natural range is primarily concentrated in the vast territories of Australia. Specifically, this species thrives across portions of the Northern Territory, adapting to its local environment. It also maintains a significant presence throughout the region of South Australia. Together, these locations define the distinct geographic footprint of this fascinating botanical specimen.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Eremophila neglecta, an Australian desert plant, has demonstrated significant biological potential through its unique chemical constituents. Research into its crude extracts has revealed potent antibacterial activity, specifically targeting various Gram-positive bacteria and certain mycobacterial isolates. The isolation of serrulatane-type diterpenoids has further highlighted the plant's medicinal value, as these compounds show promise against medically important pathogens. However, studies also indicate that these bioactive compounds possess cytotoxic properties, displaying measurable toxicity toward mammalian cells like the Vero cell line. Understanding this dual nature of antibacterial and cytotoxic activity is essential for evaluating the plant's future applicability in biomedical developments.
Compounds
Eremophila neglecta is an Australian medicinal plant that serves as the source of the unique serrulatane diterpenoid, 8-hydroxyserrulat-14-en-19-oic acid. This specific compound has demonstrated a remarkable ability to disperse established biofilms produced by bacteria such as Staphylococcus aureus and Staphylococcus epidermidis. Beyond its antimicrobial properties, the substance effectively inhibits the secretion of pro-inflammatory cytokines, including TNF-α and IL-6, from activated macrophages. Research indicates that the compound can be applied via mesh to mimic wound dressings without causing cytotoxicity to essential cells. These combined therapeutic benefits suggest that this plant-derived molecule holds significant promise for future advancements in wound management applications.
Conditions
Eremophila neglecta contains serrulatane diterpenoids that demonstrate a significant capacity for bacterial biofilm dispersion. These compounds exhibit potent antibacterial activity against a variety of Gram-positive bacteria. Specifically, the plant extracts show effectiveness against the pathogen Moraxella catarrhalis among tested Gram-negative strains. Furthermore, the medicinal plant provides antimycobacterial activity capable of treating Mycobacterium chelonae. The therapeutic potential of Eremophila neglecta is also evidenced by its ability to target Mycobacterium fortuitum.
Preparations
Eremophila neglecta is prepared as a crude extract to investigate its potential antimicrobial properties. This specific Et(2)O extract was utilized in a survey of candidate plants to identify novel bioactive compounds. Through bioassay-directed fractionation of the extract, researchers successfully isolated several serrulatane-type diterpenoids and a known naphthoquinone. These isolated compounds, derived from the initial crude preparation, demonstrated significant activity against various Gram-positive bacteria. The study highlights how the preparation of the Eremophila neglecta extract serves as the essential starting point for chemical characterization.